Last reviewed: July 1, 2026
Last updated: July 1, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has demonstrated significant weight loss results in clinical trials, with participants losing up to 15% of body weight over 68 weeks. Today, clinicians across the United States prescribe semaglutide off-label for chronic weight management in eligible patients. PlexusDx connects patients with licensed compounding pharmacies that formulate customized semaglutide injections tailored to individual metabolic profiles and genetic predispositions.
How Semaglutide Works for Weight Loss
Semaglutide functions as a glucagon-like peptide-1 (GLP-1) receptor agonist, a class of medications that mimic natural hormones regulating appetite and blood sugar. When injected weekly, semaglutide slows gastric emptying—the rate at which food leaves your stomach—creating prolonged feelings of fullness after smaller meals. This mechanism reduces total calorie intake without requiring severe dietary restriction or exhausting willpower alone.
The medication also enhances insulin secretion in response to meals and suppresses glucagon release when blood sugar drops, creating more stable energy levels throughout the day. Many patients report decreased cravings for high-calorie foods, particularly sugary and fatty options, within the first two to four weeks of treatment. These neurobiological changes address the root cause of overeating rather than treating weight loss as purely a matter of eating less and moving more.
Patient Eligibility and Clinical Assessment Criteria
Semaglutide candidates typically include adults with a BMI of 30 or higher, or those with a BMI of 27 or higher who have at least one weight-related health condition such as hypertension, type 2 diabetes, or heart disease. However, eligibility extends beyond these thresholds; patients with metabolic syndrome, insulin resistance, or a family history of diabetes may benefit even at lower BMI ranges. A thorough clinical history should assess current medications, previous weight loss attempts, and underlying medical conditions that might affect safety or efficacy.
Before prescribing semaglutide, clinicians should screen for personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia type 2 (MEN2), as GLP-1 agonists carry a boxed warning for these populations. Kidney function, liver health, and gallbladder status should be evaluated through standard laboratory panels. PlexusDx recommends completing a full metabolic assessment and considering the Precision Peptide Genetic Test to identify how your unique genetic variants in the GLP1R, GIPR, FTO, and MC4R genes may influence treatment response and optimal medication selection.
Semaglutide Dosing Protocols and Titration Schedules
Semaglutide dosing begins at a low starting dose to minimize gastrointestinal side effects and allow the body to adapt. The standard titration schedule increases the dose every four weeks, with most patients reaching an effective maintenance dose of 1.0 to 2.4 mg weekly by week 16 of treatment. Dose adjustments depend on individual tolerance, weight loss progress, and metabolic response rather than body weight alone—a principle reflected in PlexusDx's flat monthly pricing structure, which ensures your dose can increase without price increases.
Some patients achieve meaningful weight loss at lower maintenance doses (0.5–1.0 mg weekly), while others benefit from higher doses (2.0–2.4 mg weekly) to maximize appetite suppression. Compounded formulations from PlexusDx allow precise customization at each dose level, and your clinician can adjust based on real-world response. Monthly reassessment during the first three months, then quarterly evaluation thereafter, helps ensure you're receiving the optimal dose for your metabolism and lifestyle.
Managing Side Effects and Optimizing Long-Term Outcomes
Common early side effects of semaglutide include nausea, vomiting, and constipation, typically most pronounced during the first two weeks after each dose increase. These effects usually diminish within 3–7 days as the body adapts. Practical strategies include eating smaller, nutrient-dense meals; staying hydrated; taking ginger or peppermint; and using stool softeners or increased fiber intake when constipation occurs. Most patients find that side effects are manageable and far outweighed by the appetite suppression and weight loss results.
Long-term success with semaglutide requires consistent lifestyle support: a balanced diet rich in protein and vegetables, regular physical activity starting at 150 minutes weekly, and adequate sleep. PlexusDx patients gain access to personalized guidance informed by their genetic profile through the Precision Peptide Genetic Test, which reveals how their FTO and MC4R variants influence satiety patterns and food preferences. Patients who maintain semaglutide therapy typically sustain weight loss results, while those who discontinue often experience gradual weight regain over 12–24 months, making long-term medication adherence a critical factor in sustained metabolic improvement.
PlexusDx Compounded Semaglutide: Access, Pricing, and Quality Assurance
PlexusDx delivers compounded semaglutide injections prepared by licensed 503A compounding pharmacies across all 50 states, with no insurance requirement and no membership fees. Starting at $149 per month with flat pricing across three commitment tiers, PlexusDx ensures that dose escalation never triggers a price increase—your dose may go up, but your price won't. All formulations are prepared under strict pharmaceutical standards with third-party potency and purity testing, ensuring consistency and safety equivalent to brand-name medications.
Patients can use Health Savings Accounts (HSA) or Flexible Spending Accounts (FSA) to cover PlexusDx semaglutide, reducing out-of-pocket costs for those with qualifying plans. After completing one month of treatment, eligible patients can add the Precision Peptide Genetic Test ($99) to identify how genetic variants in the GLP1R, GIPR, FTO, and MC4R pathways predict your personalized response to semaglutide and other peptide therapies. Online consultations, doorstep delivery, and ongoing clinical support create a seamless experience for patients seeking convenient, affordable weight loss treatment.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Who should consider semaglutide for weight loss rather than diet and exercise alone?
Semaglutide is appropriate for adults with a BMI of 30 or higher, or BMI of 27+ with weight-related health conditions who have struggled with traditional weight loss methods. If you've attempted multiple diet-exercise programs without sustained results, semaglutide addresses the underlying hormonal drivers of overeating. A PlexusDx clinician can assess your candidacy during an online consultation.
How much weight can I expect to lose with semaglutide?
Clinical trials show average weight loss of 10–15% of body weight over 68 weeks, with some patients achieving 20% or more. Individual results vary based on baseline metabolic health, genetic predispositions, adherence to dosing and lifestyle changes, and underlying conditions. PlexusDx's Precision Peptide Genetic Test helps predict your likely response by analyzing how your FTO and MC4R variants influence energy balance and satiety.
What does semaglutide cost through PlexusDx, and can I use insurance or FSA?
PlexusDx compounded semaglutide injection starts at $149 per month with flat pricing—your dose can increase without your price increasing. No insurance is required, and HSA/FSA funds are eligible. After one month of treatment, add the Precision Peptide Genetic Test for $99 to optimize your long-term therapy plan.
What are the most common side effects, and how long do they last?
Nausea, vomiting, constipation, and reduced appetite are typical, especially after each dose increase. These effects usually resolve within 3–7 days as your body adapts. Eating small, protein-rich meals, staying hydrated, and using over-the-counter remedies (ginger, stool softeners) manage most symptoms effectively during the adjustment period.
Can genetic testing help predict how I'll respond to semaglutide?
Yes. PlexusDx's Precision Peptide Genetic Test analyzes 14 pathways and 49 peptides, including key variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite, insulin sensitivity, and weight loss potential. These insights help your clinician personalize your semaglutide dose and determine whether alternatives like tirzepatide or dual GLP-Squared therapy might optimize your metabolic outcome.
Related Reading
Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Do You See Weight Loss on Ozempic?
Is Ozempic Worth Taking? A Guide to Benefits and Risks